Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mural Oncology plc - Ordinary Shares (NQ:MURA)

1.240 -0.020 (-1.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 479,310
Open 1.240
Bid (Size) 1.230 (5)
Ask (Size) 1.280 (30)
Prev. Close 1.260
Today's Range 1.192 - 1.320
52wk Range 1.110 - 5.020
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top movers analysis one hour before the close of the markets on 2025-03-25: top gainers and losers in today's session.
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
Which stocks are experiencing notable movement on Tuesday?
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements. 
Via Chartmill

Performance

YTD
-61.3%
-61.3%
1 Month
-63.8%
-63.8%
3 Month
-61.5%
-61.5%
6 Month
-60.4%
-60.4%
1 Year
-74.4%
-74.4%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Nasdaq Gains 50 Points; US New Home Sales Rise In February
Via Benzinga
Which stocks are moving before the opening bell on Tuesday?
Via Chartmill
US Stocks Mixed; Core & Main Posts Downbeat Earnings
Via Benzinga
Mural Oncology's Ovarian Cancer Combo Drug Trial Disappoints, Stock Plunges
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Power Solutions International Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Mural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Platinum-Resistant Ovarian Cancer
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical Milestones
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology to Present at the TD Cowen 45th Annual Health Care Conference
From Mural Oncology, Inc.
Via GlobeNewswire
This Vital Farms Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Mural Oncology Highlights Pipeline Progress and Anticipated 2025 Catalysts
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology to Participate in Two Upcoming Investor Conferences
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Mural Oncology, Inc.
Via GlobeNewswire
Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
From Mural Oncology, Inc.
Via GlobeNewswire
This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Mural Oncology plc - Ordinary Shares publicly traded?
Yes, Mural Oncology plc - Ordinary Shares is publicly traded.
What exchange does Mural Oncology plc - Ordinary Shares trade on?
Mural Oncology plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Mural Oncology plc - Ordinary Shares?
The ticker symbol for Mural Oncology plc - Ordinary Shares is MURA on the Nasdaq Stock Market
What is the current price of Mural Oncology plc - Ordinary Shares?
The current price of Mural Oncology plc - Ordinary Shares is 1.240
When was Mural Oncology plc - Ordinary Shares last traded?
The last trade of Mural Oncology plc - Ordinary Shares was at 04/01/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.